Problem:
You have been contracted by the Biotech company FastHeal to produce a slowrelease growth factor product aimed at the chronic wound repair market.
a) In the first stage of the work, they have asked you to present them with alternative strategies for developing a growth factor releasing product.
Question: Briefly describe two alternative approaches for presenting the growth factor in a form suitable for application to a wound.
b) The Biotech company next ask you for proof of principle for one of your two suggestions.
Question: Design an in vitro experiment with appropriate controls to demonstrate the release kinetics of the growth factor from your product.